
Broadcom Inc.
- What it sells
- Products is 70% of revenue (fiscal year to Oct 2025), down from 81% two years earlier.
- Growing?
- Yes: revenue up 86% on a year earlier (quarter ended Jul 2026); earnings per share up 100% over the last four quarters.
- Expensive?
- About usual: 46.5× trailing earnings; its five-year median is 46.1×. Priced 193% above the peer median of 15.9x (excludes 1 unprofitable peer).
- Analysts?
- 96% of 51 say buy; average 12-month target $533, 46% above today's price.
- Risky?
- Swingier than most large companies: its price swung 48% over the past year (the S&P 500's 14%), and it fell as much as 41% since Nov 2021.
Broadcom Inc. designs and supplies semiconductor solutions (e.g., custom ASICs, Ethernet switching, broadband/optical connectivity, RF/wireless components, and storage connectivity) and infrastructure software (including VMware virtualization/private cloud and legacy mainframe/enterprise software), monetized primarily via chip sales plus software subscriptions/support.
More about Broadcom
It sells largely to hyperscale/cloud, enterprise, and OEM customers through direct sales and channel partners.
Market Position
Broadcom is a scaled, diversified supplier in data center networking and connectivity and a major provider of enterprise infrastructure software post-VMware, with differentiation rooted in high-performance, high-reliability silicon, long product lifecycles, and deep engagement with large platform customers. Its competitive set spans merchant silicon and custom silicon vendors and large infrastructure software providers.
Key Segments
Broadcom reports two primary segments: Semiconductor Solutions and Infrastructure Software (which includes VMware and other enterprise/mainframe software assets).
How has the stock done?
Over the past month AVGO rose 2.7%; the semiconductor ETF (SMH) fell 15.1% and the S&P 500 fell 2.7%. 1 Congress filing by portfolios that hold it fall in this period.
Over the past six months AVGO fell 13.1%; the semiconductor ETF (SMH) fell 10.6% and the S&P 500 rose 2.6%. 1 Congress filing by portfolios that hold it fall in this period.
Over the past year AVGO rose 2.6%; the semiconductor ETF (SMH) rose 41.1% and the S&P 500 rose 10.8%. 1 Congress filing by portfolios that hold it fall in this period.
Over five years AVGO rose 546.9%; the semiconductor ETF (SMH) rose 233.3% and the S&P 500 rose 62.0%. 1 Congress filing by portfolios that hold it fall in this period.
From Dec 16, 2024 to Apr 4, 2025, the deepest drop from a high since Nov 2021
How much the price swings in a year; the S&P 500's was 14%
When the S&P 500 moves 1%, the stock has moved about 2.2% the same way
Show the Congress filings
| Filed | Portfolio | AVGO in the filing | Latest trade in filing | AVGO share |
|---|---|---|---|---|
| Nov 6, 2026 | Nancy Pelosi | No AVGO trade in it | Oct 7, 2026 | 13.1% |
Show the earnings releases
| Released | Quarter | Revenue | EPS vs estimate | Stock, day after | 5 days after |
|---|---|---|---|---|---|
| Sep 2, 2026 | ended Jul 2026 | $29.6B (+86% vs a year earlier) | $3.32 vs $3.24 (beat) | −3.4% | −2.4% |
| Jun 3, 2026 | ended Apr 2026 | $22.2B (+48% vs a year earlier) | $2.44 vs $2.40 (beat) | −13.0% | −22.7% |
| Mar 4, 2026 | ended Jan 2026 | $19.3B (+29% vs a year earlier) | $2.05 vs $2.02 (beat) | +6.0% | +8.8% |
| Dec 11, 2025 | ended Oct 2025 | $18.0B (+28% vs a year earlier) | $1.95 vs $1.87 (beat) | −12.8% | −20.1% |
| Sep 4, 2025 | ended Jul 2025 | $16.0B (+22% vs a year earlier) | — | +10.7% | +18.9% |
| Jun 5, 2025 | ended Apr 2025 | $15.0B (+20% vs a year earlier) | — | −5.4% | −1.9% |
| Mar 6, 2025 | ended Jan 2025 | $14.9B (+25% vs a year earlier) | — | +1.8% | −0.1% |
| Dec 12, 2024 | ended Oct 2024 | $14.1B (+51% vs a year earlier) | — | +22.7% | +19.2% |
| Sep 5, 2024 | ended Jul 2024 | $13.1B (+47% vs a year earlier) | — | −11.1% | +6.8% |
| Jun 12, 2024 | ended Apr 2024 | $12.5B (+43% vs a year earlier) | — | +14.9% | +18.7% |
| Mar 7, 2024 | ended Jan 2024 | $12.0B (+34% vs a year earlier) | — | −3.1% | −6.5% |
| Dec 7, 2023 | ended Oct 2023 | $9.3B (+4% vs a year earlier) | — | +4.5% | +22.4% |
| Aug 31, 2023 | ended Jul 2023 | $8.9B (+5% vs a year earlier) | — | −2.2% | −3.9% |
| Jun 1, 2023 | ended Apr 2023 | $8.7B (+8% vs a year earlier) | — | +0.5% | −0.5% |
| Mar 2, 2023 | ended Jan 2023 | $8.9B (+16% vs a year earlier) | — | +6.6% | +4.9% |
| Dec 8, 2022 | ended Oct 2022 | $8.9B (+21% vs a year earlier) | — | +5.1% | +7.6% |
| Sep 1, 2022 | ended Jul 2022 | $8.5B (+25% vs a year earlier) | — | +0.2% | +4.7% |
| May 26, 2022 | ended Apr 2022 | $8.1B (+23% vs a year earlier) | — | +9.7% | +6.0% |
| Mar 3, 2022 | ended Jan 2022 | $7.7B (+16% vs a year earlier) | — | +1.7% | +0.3% |
| Dec 9, 2021 | ended Oct 2021 | $7.4B (+15% vs a year earlier) | — | +7.3% | +5.5% |
Change in closing price from the first day shown, or with Price the closing price itself. Prices: Yahoo Finance, to Nov 12, 2026. Dots on the line: a member of Congress whose Hunch portfolio holds AVGO filed a disclosure; its hover says what the disclosure reports of AVGO: each trade, bought or sold, with the amount range the member filed (the House asks for a range, not the amount), or in an annual report the range of the holding’s value, the ranges of its entries added up (“in all”) where the report lists AVGO more than once, in several accounts or share classes: a sum that bounds the value as the ranges do but is not a range the form offers. An annual report’s row has no latest trade. Filings: the Clerk of the House. Dashed lines: the days the company released earnings (its SEC 8-K filings); EPS estimates: Yahoo Finance. The stock's move after a release runs from the last close before its day to the close the day after (or five days after), so a release before the open counts like one after the close.
Is the business growing?
Revenue was $29.6B in the quarter ended Jul 2026, up 86% from a year earlier.
Show the data
| Quarter ended | Revenue | vs a year earlier |
|---|---|---|
| Oct 2022 | $8.9B | +21% |
| Jan 2023 | $8.9B | +16% |
| Apr 2023 | $8.7B | +8% |
| Jul 2023 | $8.9B | +5% |
| Oct 2023 | $9.3B | +4% |
| Jan 2024 | $12.0B | +34% |
| Apr 2024 | $12.5B | +43% |
| Jul 2024 | $13.1B | +47% |
| Oct 2024 | $14.1B | +51% |
| Jan 2025 | $14.9B | +25% |
| Apr 2025 | $15.0B | +20% |
| Jul 2025 | $16.0B | +22% |
| Oct 2025 | $18.0B | +28% |
| Jan 2026 | $19.3B | +29% |
| Apr 2026 | $22.2B | +48% |
| Jul 2026 | $29.6B | +86% |
Revenue went from $33.2B in FY22 to $63.9B in FY25; net income from $11.5B to $23.1B.
Show the data
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY22 | $33.2B | $11.5B |
| FY23 | $35.8B | $14.1B |
| FY24 | $51.6B | $5.9B |
| FY25 | $63.9B | $23.1B |
In the fiscal year to Oct 2025, Products was 70% and Subscriptions and services was 30% of revenue; Subscriptions and services rose from 19% in the fiscal year to Oct 2023.
Show the data
| Fiscal year | Part | Revenue | Share |
|---|---|---|---|
| FY2023 | Products | $28.9B | 81% |
| FY2023 | Subscriptions and services | $6.9B | 19% |
| FY2024 | Products | $35.0B | 68% |
| FY2024 | Subscriptions and services | $16.6B | 32% |
| FY2025 | Products | $44.8B | 70% |
| FY2025 | Subscriptions and services | $19.0B | 30% |
A year earlier $0.85
Diluted, from SEC filings
Quarters: Broadcom Inc.'s SEC filings, named by the month they end. Fiscal years: Broadcom Inc.'s annual reports to the SEC.
How it makes money
Of every $100 in revenue, $36.2 ends up as net income. Net margin rose from 34.6% to 36.2% over the past 3 years.
+1.2 pts over 3 years
−3.0 pts over 3 years
+1.6 pts over 3 years
Each margin is that line of the income statement divided by revenue. Fiscal year: Broadcom Inc.'s annual reports to the SEC.
Where it is in the chip cycle
Gross margin 69.1%, up 2.0 points from a year earlier; inventory at 40 days, up from 34 a year earlier; capital spending 1.4% of revenue over the last 4 quarters.
Show the data
| Period | Inventory days |
|---|---|
| FY22 | 63 |
| FY23 | 62 |
| FY24 | 34 |
| FY25 | 40 |
How many days of sales are sitting in stock. Rising inventory days often come before a downturn: chips are being made faster than they sell.
Show the data
| Period | Capital spending |
|---|---|
| Jul ’25 | 0.9% |
| Oct ’25 | 1.3% |
| Jan ’26 | 1.3% |
| Apr ’26 | 1.0% |
| Jul ’26 | 1.8% |
Money put into factories and equipment. Heavy spending late in an upswing can leave the industry with too much capacity when demand cools.
Gross margin by fiscal quarter, from SEC filings. Inventory days: year-end inventory over that year's cost of revenue, times 365.
Customers and suppliers
In its latest annual report Broadcom buys from TSMC, ASE Technology, Hon Hai Precision Industry and 1 more; one customer it does not name accounts for 32% of its revenue. Cisco Systems’s Supplier List for fiscal 2025 names Broadcom as a supplier.
Their suppliers
Suppliers
Customers
Their customers
Broadcom's 10-K for the year to Oct 2025 gives one customer's share of its revenue: Major Customer One (32%).
Show the filings' numbers
| Period | Customer | Share of revenue | Filing |
|---|---|---|---|
| Year ended Oct 2024 | Major Customer One | 28% | 10-K filed Dec 18, 2025 |
| Year ended Oct 2025 | Major Customer One | 32% | 10-K filed Dec 18, 2025 |
From Broadcom Inc.'s 10-Q and 10-K filings (XBRL): each customer whose share of revenue a filing tags, under the filing's own label, so “Customer A” in one filing can be another company in the next; a later filing's figures for a period replace an earlier one's.
Changes since the previous annual report (10-K filed Dec 20, 2024)
Show the filing's words
| Company | Role | In the filing's words |
|---|---|---|
| TSMC | supplier | “The majority of our front-end wafer manufacturing operations is outsourced to external foundries, including Taiwan Semiconductor Manufacturing Company Limited (“TSMC”)....During fiscal year 2025, approximately 95% of the wafers manufactured by our CMs were produced by TSMC.” |
| ASE Technology | supplier | “We use third-party CMs for a significant majority of our assembly and test operations, including TSMC, Advanced Semiconductor Engineering, Inc., Foxconn Technology Group, Amkor Technology, Inc. and Siliconware Precision Industries Co., Ltd.” |
| Hon Hai Precision Industry | supplier | “We use third-party CMs for a significant majority of our assembly and test operations, including TSMC, Advanced Semiconductor Engineering, Inc., Foxconn Technology Group, Amkor Technology, Inc. and Siliconware Precision Industries Co., Ltd.” |
| Amkor Technology | supplier | “We use third-party CMs for a significant majority of our assembly and test operations, including TSMC, Advanced Semiconductor Engineering, Inc., Foxconn Technology Group, Amkor Technology, Inc. and Siliconware Precision Industries Co., Ltd.” |
| One semiconductor solutions customer, which is a distributor (unnamed) | customer | “Direct sales to one semiconductor solutions customer, which is a distributor, accounted for 32% and 28% of our net revenue for fiscal years 2025 and 2024, respectively.” |
| Arista Networks (10-K filed Feb 17, 2026) | co-develops with it | “Our product development efforts also depend upon continued collaboration with our key suppliers, such as Broadcom. As we develop our product roadmap and continue to expand our relationships with these and other merchant silicon vendors, it is crucial that we collaborate closely with our key merchant silicon vendors to ensure that their silicon incorporates enhanced features and that our products leverage these improvements.” |
| Arista Networks (10-K filed Feb 17, 2026) | calls it a supplier | “In particular, we are primarily reliant upon our predominant merchant silicon vendor, Broadcom, for our switching chips.” |
| Cisco Systems (Supplier List published Apr 18, 2026) | calls it a supplier | “Broadcom, Inc.” |
| Everpure (10-K filed Mar 25, 2026) | calls it a partner | “Our technology partners include application partners such as VMware, RedHat, Nutanix, Microsoft, Oracle and SAP, cloud partners such as Microsoft Azure, AWS, Google, and IBM, data protection partners such as Commvault, Rubrik and Veeam, and infrastructure partners such as Cisco and NVIDIA.” |
| Fortinet (10-K filed Feb 25, 2026) | calls it a supplier | “Our limited source components for particular appliances and suppliers of those components include specific types of CPUs from Intel and AMD, network and wireless chips from Broadcom, Marvell, Qualcomm and Intel, and memory devices from Intel, Micron, ADATA, Toshiba, Samsung and Western Digital.” |
| Hewlett-Packard Enterprise (10-K filed Dec 18, 2025) | calls it a supplier | “In some instances, our single-source suppliers (e.g., Intel and AMD as suppliers of certain x86 processors Broadcom and others for industry standard Application-Specific Standard Product, or NVIDIA for Graphics Processing Units) are also the single-source suppliers for the entire market; disruptions with these suppliers would result in industry-wide dislocations and therefore would not disproportionately disadvantage us relative to our competitors.” |
| UMC (20-F filed Apr 30, 2026) | licensing deal with it | “We have entered into various patent cross-licenses with major technology companies, including a number of leading international semiconductor companies, such as IBM and Broadcom Inc.” |
Only the companies Broadcom names in its 10-K filed Dec 18, 2025 (SEC). Named in other companies' filings: those whose own latest annual report or an 8-K since names Broadcom. The supply chain joins the latest annual reports of the companies on it and the 8-Ks they filed since: a link shows when either side's report names the other, so it grows as more reports are read. Also from other documents: Cisco Systems’s Supplier List for fiscal 2025, published Apr 18, 2026 (source). Hover a name for the filing's own words. Customers it does not name are listed as the filing describes them.
Is it expensive?
P/E of 46.5x, above the peer median of 15.9x, so it needs earnings to keep growing to hold up.
Priced 193% above the peer median of 15.9x (excludes 1 unprofitable peer).
Show the data
| Company | P/E (trailing) |
|---|---|
| AMD · Advanced Micro Devices, Inc. | 127× |
| AVGO · Broadcom Inc. | 46.5× |
| NVDA · NVIDIA Corporation | 21× |
| MU · Micron Technology, Inc. | 10.8× |
| SKHY · SK hynix Inc. | 8.8× |
| INTC · Intel Corporation | Loss |
At 46.5× trailing earnings AVGO is inside the middle of its five-year range; the five-year median is 46.1×.
Show the data
| Date | Trailing P/E |
|---|---|
| Nov 8, 2021 | 41.5× |
| Feb 8, 2022 | 40.0× |
| May 10, 2022 | 33.1× |
| Aug 10, 2022 | 27.3× |
| Nov 8, 2022 | 20.8× |
| Feb 9, 2023 | 22.6× |
| May 11, 2023 | 21.1× |
| Aug 11, 2023 | 26.0× |
| Nov 9, 2023 | 28.1× |
| Feb 12, 2024 | 38.4× |
| May 13, 2024 | 49.6× |
| Aug 13, 2024 | 67.3× |
| Nov 11, 2024 | 156× |
| Feb 13, 2025 | 195× |
| May 15, 2025 | 112× |
| Aug 15, 2025 | 115× |
| Nov 13, 2025 | 87.0× |
| Feb 17, 2026 | 69.9× |
| May 18, 2026 | 82.2× |
| Aug 18, 2026 | 63.3× |
| Nov 12, 2026 | 46.5× |
Closing price over diluted earnings per share of the last four reported quarters, as known on each day (a quarter counts 35 days after it ends). From SEC filings; earnings per share adjusted for splits.
What analysts expect
The average analyst price target is $533, 46% above the current price; 96% of 51 analysts rate it a buy; earnings beat estimates in all of the last 4 quarters.
Buy or Strong Buy: 49 analysts (96%). Sell or Strong Sell: 0.
Over the past year the average of the analysts' latest price targets went from $381.74 to $522.92 (+37%), while AVGO went from $339.98 to $364.36 (+7%). In the past three months targets were raised 7 times and cut 4 times. 3 upgrades and 3 downgrades over the year; the latest: DA Davidson moved it to Buy from Neutral on Oct 27, 2026.
Show every change
| Date | Firm | Change | Rating | Target |
|---|---|---|---|---|
| Oct 27, 2026 | Rosenblatt | Target kept | Buy | $600.00 |
| Oct 27, 2026 | DA Davidson | Upgrade | Buy, was Neutral | $400.00, was $350.00 |
| Oct 22, 2026 | Tigress Financial | Began coverage | Buy | $600.00 |
| Sep 10, 2026 | Piper Sandler | Began coverage | Overweight | $460.00 |
| Sep 4, 2026 | Citigroup | Target raised | Buy | $515.00, was $500.00 |
| Sep 4, 2026 | DA Davidson | Target cut | Neutral | $350.00, was $400.00 |
| Sep 3, 2026 | Macquarie | Upgrade | Outperform, was Neutral | $490.00 |
| Sep 3, 2026 | Raymond James | Target raised | Outperform | $475.00, was $450.00 |
| Sep 3, 2026 | Evercore ISI Group | Target cut | Outperform | $578.00, was $582.00 |
| Sep 3, 2026 | TD Cowen | Target cut | Buy | $475.00, was $500.00 |
| Sep 3, 2026 | Truist Securities | Target cut | Buy | $520.00, was $550.00 |
| Sep 3, 2026 | StoneX | Target kept | Buy | $545.00 |
| Sep 3, 2026 | Morgan Stanley | Target raised | Overweight | $505.00, was $502.00 |
| Sep 3, 2026 | RBC Capital | Target kept | Sector Perform | $400.00 |
| Sep 3, 2026 | Keybanc | Target kept | Overweight | $575.00 |
| Sep 3, 2026 | Rosenblatt | Target raised | Buy | $600.00, was $500.00 |
| Sep 3, 2026 | BMO Capital | Target raised | Outperform | $575.00, was $455.00 |
| Sep 3, 2026 | Cantor Fitzgerald | Target raised | Overweight | $600.00, was $525.00 |
| Aug 26, 2026 | RBC Capital | Target kept | Sector Perform | $400.00 |
| Aug 21, 2026 | BMO Capital | Began coverage | Outperform | $455.00 |
| Jul 7, 2026 | Erste Group | Downgrade | Hold, was Buy | — |
| Jun 4, 2026 | UBS | Target cut | Buy | $485.00, was $490.00 |
| Jun 4, 2026 | B of A Securities | Target raised | Buy | $530.00, was $450.00 |
| Jun 4, 2026 | Mizuho | Target raised | Outperform | $530.00, was $480.00 |
| Jun 4, 2026 | Oppenheimer | Target raised | Outperform | $535.00, was $450.00 |
| Jun 4, 2026 | Macquarie | Downgrade | Neutral, was Outperform | $437.00 |
| Jun 4, 2026 | JP Morgan | Target raised | Overweight | $580.00, was $500.00 |
| Jun 4, 2026 | Jefferies | Target raised | Buy | $550.00, was $500.00 |
| Jun 4, 2026 | DA Davidson | Target raised | Neutral | $400.00, was $375.00 |
| Jun 4, 2026 | TD Cowen | Target kept | Buy | $500.00 |
| Jun 4, 2026 | Truist Securities | Target raised | Buy | $550.00, was $545.00 |
| Jun 4, 2026 | Rosenblatt | Target kept | Buy | $500.00 |
| Jun 4, 2026 | RBC Capital | Target raised | Sector Perform | $400.00, was $360.00 |
| Jun 4, 2026 | Cantor Fitzgerald | Target kept | Overweight | $525.00 |
| Jun 4, 2026 | Morgan Stanley | Target raised | Overweight | $502.00, was $485.00 |
| Jun 4, 2026 | Keybanc | Target raised | Overweight | $575.00, was $500.00 |
| Jun 4, 2026 | Benchmark | Target raised | Buy | $545.00, was $485.00 |
| Jun 4, 2026 | Deutsche Bank | Target raised | Buy | $515.00, was $430.00 |
| Jun 1, 2026 | Morgan Stanley | Target raised | Overweight | $485.00, was $470.00 |
| May 28, 2026 | Susquehanna | Target raised | Positive | $490.00, was $450.00 |
| May 18, 2026 | UBS | Target raised | Buy | $490.00, was $475.00 |
| May 15, 2026 | TD Cowen | Target raised | Buy | $500.00, was $405.00 |
| May 14, 2026 | Wells Fargo | Target raised | Overweight | $545.00, was $430.00 |
| May 12, 2026 | Citigroup | Target raised | Buy | $500.00, was $475.00 |
| Apr 16, 2026 | Mizuho | Target kept | Outperform | $480.00 |
| Apr 15, 2026 | Wells Fargo | Target kept | Overweight | $430.00 |
| Apr 15, 2026 | JP Morgan | Target kept | Overweight | $500.00 |
| Apr 14, 2026 | Cantor Fitzgerald | Target kept | Overweight | $525.00 |
| Apr 14, 2026 | Citigroup | Target kept | Buy | $475.00 |
| Apr 14, 2026 | Bernstein | Target kept | Outperform | $525.00 |
| Apr 13, 2026 | UBS | Target kept | Buy | $475.00 |
| Apr 8, 2026 | Seaport Global | Downgrade | Neutral, was Buy | — |
| Apr 7, 2026 | Rosenblatt | Target kept | Buy | $500.00 |
| Mar 6, 2026 | Morgan Stanley | Target raised | Overweight | $470.00, was $462.00 |
| Mar 5, 2026 | JP Morgan | Target raised | Overweight | $500.00, was $475.00 |
| Mar 5, 2026 | Citigroup | Target raised | Buy | $475.00, was $458.00 |
| Mar 5, 2026 | Truist Securities | Target raised | Buy | $545.00, was $510.00 |
| Mar 5, 2026 | RBC Capital | Target raised | Sector Perform | $360.00, was $340.00 |
| Mar 5, 2026 | Evercore ISI Group | Target raised | Outperform | $582.00, was $490.00 |
| Mar 5, 2026 | Rosenblatt | Target raised | Buy | $500.00, was $450.00 |
| Mar 5, 2026 | Benchmark | Target kept | Buy | $485.00 |
| Mar 5, 2026 | B of A Securities | Target cut | Buy | $450.00, was $500.00 |
| Mar 2, 2026 | RBC Capital | Target cut | Sector Perform | $340.00, was $370.00 |
| Feb 17, 2026 | Citigroup | Target cut | Buy | $458.00, was $480.00 |
| Feb 13, 2026 | DA Davidson | Began coverage | Neutral | $335.00 |
| Jan 15, 2026 | Wells Fargo | Upgrade | Overweight, was Equal-Weight | $430.00, was $410.00 |
| Jan 15, 2026 | RBC Capital | Began coverage | Sector Perform | $370.00 |
| Jan 9, 2026 | Mizuho | Target raised | Outperform | $480.00, was $450.00 |
| Dec 19, 2025 | Truist Securities | Target raised | Buy | $510.00, was $500.00 |
| Dec 15, 2025 | UBS | Target raised | Buy | $475.00, was $472.00 |
| Dec 12, 2025 | Citigroup | Target raised | Buy | $480.00, was $415.00 |
| Dec 12, 2025 | Barclays | Target raised | Overweight | $500.00, was $450.00 |
| Dec 12, 2025 | JP Morgan | Target raised | Overweight | $475.00, was $400.00 |
| Dec 12, 2025 | TD Cowen | Target raised | Buy | $450.00, was $405.00 |
| Dec 12, 2025 | Morgan Stanley | Target raised | Overweight | $462.00, was $443.00 |
| Dec 12, 2025 | Piper Sandler | Target raised | Overweight | $430.00, was $375.00 |
| Dec 12, 2025 | Oppenheimer | Target raised | Outperform | $450.00, was $435.00 |
| Dec 12, 2025 | Mizuho | Target raised | Outperform | $450.00, was $435.00 |
| Dec 12, 2025 | Bernstein | Target raised | Outperform | $475.00, was $400.00 |
| Dec 12, 2025 | Benchmark | Target raised | Buy | $485.00, was $385.00 |
| Dec 12, 2025 | Rosenblatt | Target raised | Buy | $450.00, was $440.00 |
| Dec 12, 2025 | B of A Securities | Target raised | Buy | $500.00, was $460.00 |
| Dec 12, 2025 | Keybanc | Target raised | Overweight | $500.00, was $460.00 |
| Dec 9, 2025 | Rosenblatt | Target raised | Buy | $440.00, was $400.00 |
| Dec 5, 2025 | Oppenheimer | Target raised | Outperform | $435.00, was $400.00 |
| Dec 4, 2025 | Susquehanna | Target raised | Positive | $450.00, was $400.00 |
| Dec 1, 2025 | Morgan Stanley | Target raised | Overweight | $443.00, was $409.00 |
| Dec 1, 2025 | B of A Securities | Target raised | Buy | $460.00, was $400.00 |
| Dec 1, 2025 | UBS | Target raised | Buy | $472.00, was $415.00 |
| Nov 26, 2025 | Goldman Sachs | Target raised | Buy | $435.00, was $380.00 |
Show the data
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct ’25 | $1.87 | $1.95 | +4.3% |
| Jan ’26 | $2.02 | $2.05 | +1.5% |
| Apr ’26 | $2.40 | $2.44 | +1.7% |
| Jul ’26 | $3.24 | $3.32 | +2.5% |
The day after each of these reports the stock moved −12.8% (Oct 2025, beat); +6.0% (Jan 2026, beat); −13.0% (Apr 2026, beat); −3.4% (Jul 2026, beat).
For the quarter ending Oct 2026 (Broadcom reports on Dec 9, 2026), analysts expect adjusted earnings of $3.84 a share, 97% more than the $1.95 of a year earlier, and revenue of $34.9B, up 94% on a year earlier. For the fiscal year ending Oct 2027, they expect adjusted earnings of $19.47 a share, 67% more than the year before's estimate of $11.67, and revenue of $175.5B, up 66% on the year before's estimate.
Adjusted. Oct 2025: $1.95; range $3.69 to $3.92; 40 analysts
Oct 2025: $18.0B; range $34.7B to $35.6B; 38 analysts
Adjusted. The year to Oct 2026: $11.67 expected; range $17.47 to $22.44; 48 analysts
The year to Oct 2026: $106.0B expected; range $163.1B to $200.1B; 48 analysts
Show the data
| Period | Figure | Expected | Low to high | Analysts | A year earlier | Change |
|---|---|---|---|---|---|---|
| Quarter ending Oct 2026, results Dec 9, 2026 | EPS (adjusted) | $3.84 | $3.69 to $3.92 | 40 | $1.95 (Oct 2025) | +97% |
| Quarter ending Oct 2026, results Dec 9, 2026 | Revenue | $34.9B | $34.7B to $35.6B | 38 | $18.0B (Oct 2025) | +94% |
| Quarter ending Jan 2027 | EPS (adjusted) | $4.10 | $3.70 to $4.30 | 36 | $2.05 (Jan 2026) | +100% |
| Quarter ending Jan 2027 | Revenue | $37.0B | $34.1B to $38.8B | 34 | $19.3B (Jan 2026) | +92% |
| Year ending Oct 2026 | EPS (adjusted) | $11.67 | $11.50 to $12.38 | 48 | — | — |
| Year ending Oct 2026 | Revenue | $106.0B | $105.8B to $106.7B | 41 | $63.9B (year to Oct 2025) | +66% |
| Year ending Oct 2027 | EPS (adjusted) | $19.47 | $17.47 to $22.44 | 48 | $11.67 (expected, year to Oct 2026) | +67% |
| Year ending Oct 2027 | Revenue | $175.5B | $163.1B to $200.1B | 48 | $106.0B (expected, year to Oct 2026) | +66% |
Targets, ratings and earnings estimates: Yahoo Finance. Rating and target changes: Yahoo Finance's list of upgrades and downgrades. The average target on each day is the average of every listed firm's latest target set in the 180 days before it, so it counts fewer analysts than the average target above, and the band is the middle half of those targets (a quarter of the firms are above it, a quarter below); a target set before a stock split is divided by the split. Expected figures: the average of the analysts' estimates (Yahoo Finance). Their EPS is adjusted, as analysts estimate it, so it is set against the adjusted EPS Yahoo reports for the same quarters, not the GAAP EPS of the growth and valuation sections; revenue against the SEC filings. No change is given against a quarter whose reported EPS was more than 50% off its own estimate (often a one-off gain or charge), nor against a year that counts one. Each estimate is pinned to its fiscal period by the report date or the period's end, and one that cannot be is left out.
Where the cash goes
Generated $39.4B in free cash flow over the year, of which $20.5B went back to shareholders (dividends plus buybacks), leaving $18.9B in the company.
Show the data
| Line | Amount |
|---|---|
| Op. cash flow | $40.7B |
| Capex | −$1.3B |
| Free cash flow | $39.4B |
| Dividends | −$12.1B |
| Buybacks | −$8.4B |
| Cash retained | $18.9B |
For every $100 of market cap, the company generates about $2.3 in free cash flow a year.
For every $100 of market cap, you receive about $0.7 in dividends a year.
Dividends plus buybacks over the last four quarters: for every $100 of market cap, about $1.2 went back to shareholders.
Show the data
| Quarter ended | Free cash flow | Dividends | Buybacks |
|---|---|---|---|
| Oct 2023 | $4.7B | $1.9B | $123M |
| Jan 2024 | $4.7B | $2.4B | $7.2B |
| Apr 2024 | $4.4B | $2.4B | $0 |
| Jul 2024 | $4.8B | $2.5B | $0 |
| Oct 2024 | $5.5B | $2.5B | $0 |
| Jan 2025 | $6.0B | $2.8B | $0 |
| Apr 2025 | $6.4B | $2.8B | $2.5B |
| Jul 2025 | $7.0B | $2.8B | $0 |
| Oct 2025 | $7.5B | $2.8B | $0 |
| Jan 2026 | $8.0B | $3.1B | $7.8B |
| Apr 2026 | $10.3B | $3.1B | $600M |
| Jul 2026 | $13.7B | $3.1B | $0 |
Free cash flow: operating cash flow minus capital spending on property, plant and equipment, from SEC filings, for the last 4 quarters and by quarter.
Financial health
Current ratio 1.7, no pressure to repay short-term debt; debt-to-equity 0.8, debt is moderate.
Assets that can be turned into cash soon are 1.7x what is owed within a year. 1.5 or higher is comfortable; below 1 needs watching.
For every $1 of shareholder funds, there is $0.8 of debt. The higher the number, the more pressure when the economy weakens.
Cash and short-term investments of $16.2B against debt of $65.1B.
Latest fiscal year balance sheet. Source: Yahoo Finance.
Who holds it
21 portfolios Hunch tracks hold AVGO: 1 member of Congress and 20 funds. It is 20.2% of Blue Whale Capital's portfolio (6.4% as filed).
FundBlue Whale CapitalAVGO is 20% of this portfolio+78.0%
FundLight Street Capital ManagementAVGO is 17% of this portfolio+117.6%
FundPolen Capital ManagementAVGO is 15% of this portfolio+40.5%
FundMichael & Susan Dell FoundationAVGO is 15% of this portfolio+341.2%
FundTensor Edge CapitalAVGO is 15% of this portfolio-13.5%
CongressNancy PelosiAVGO is 13% of this portfolio+33.0%
15 more portfolios hold AVGO
- UNICOM SystemsFund · 12.9% (7.8% as filed)
- Temasek Holdings (Private)Fund · 12.4% (3.4% as filed)
- Patient Capital ManagementFund · 11.6% (2.8% as filed)
- Canada Pension Plan Investment BoardFund · 11.1% (2.7% as filed)
- Coatue ManagementFund · 9.4% (4.5% as filed)
- Stony Point CapitalFund · 9.2% (5.4% as filed)
- Norges BankFund · 9.1% (2.5% as filed)
- Bridgewater AssociatesFund · 8.7% (2.0% as filed)
- Nan Shan Life InsuranceFund · 7.2% (2.7% as filed)
- Swiss National BankFund · 6.9% (2.3% as filed)
- Mirae Asset Global InvestmentsFund · 6.5% (2.4% as filed)
- RK Capital ManagementFund · 5.6% (5.0% as filed)
- Tiger Global ManagementFund · 5.2% (2.8% as filed)
- Jia Investment AllianceFund · 4.5% (2.5% as filed)
- Harvard ManagementFund · 3.6% (3.0% as filed)
AVGO's weight in each portfolio is its target weight in the copy Hunch follows: the stocks of the latest filing that the app can trade, their weights scaled up to add to 100%. “As filed” is its weight in the filing itself: a fund’s latest 13F, or a member of Congress’s holdings from the last annual report and the trades disclosed since, each at the low end of its range. Returns are backtests based on public filings, not actual trading results. Photo credits
What did the funds Hunch tracks do?
Of the 83 funds whose 13F filings Hunch reads, 36 held AVGO at the end of their latest quarter (for most, Q2 2026). Over that quarter 13 added shares, 15 cut, 5 bought new, 3 sold all and 3 held the same. The largest of them is Norges Bank, 65.97M shares worth $24.9B at Jun 30, 2026, 5.9% fewer than at Dec 31, 2025.
5 of them new holders
3 of them sold all
Show every fund
| Fund | Quarter | Shares | Value | Change in shares | Change | Filed |
|---|---|---|---|---|---|---|
| Norges Bank | Q2 2026 vs Q4 2025 | 65.97M | $24.9B | −4.10M | −5.9% | Aug 12, 2026 |
| Fisher Asset Management | Q3 2026 | 15.48M | $5.4B | +351,196 | +2.3% | Nov 6, 2026 |
| Canada Pension Plan Investment Board | Q2 2026 | 13.02M | $4.9B | +2.73M | +27% | Aug 14, 2026 |
| Swiss National Bank | Q3 2026 | 12.36M | $4.3B | −324,240 | −2.6% | Nov 12, 2026 |
| National Pension Service | Q3 2026 | 9.66M | $3.4B | +49,501 | +0.5% | Nov 12, 2026 |
| Coatue Management | Q2 2026 | 5.85M | $2.2B | +342,979 | +6.2% | Aug 14, 2026 |
| Mirae Asset Global Investments | Q3 2026 | 3.96M | $1.4B | +404,377 | +11% | Nov 3, 2026 |
| Temasek Holdings (Private) | Q3 2026 | 3.50M | $1.2B | −240,099 | −6.4% | Oct 28, 2026 |
| Korea Investment | Q2 2026 | 3.21M | $1.2B | −89,392 | −2.7% | Aug 12, 2026 |
| Polen Capital Management | Q2 2026 | 1.96M | $740M | −737,358 | −27% | Aug 4, 2026 |
| Tiger Global Management | Q2 2026 | 1.75M | $663M | −1.83M | −51% | Aug 14, 2026 |
| Baillie Gifford & | Q3 2026 | 1.43M | $503M | +74,708 | +5.5% | Nov 9, 2026 |
| Bridgewater Associates | Q2 2026 | 1.32M | $498M | −517,457 | −28% | Aug 14, 2026 |
| Blue Whale Capital | Q2 2026 | 530,478 | $200M | +90,992 | +21% | Aug 13, 2026 |
| Michael & Susan Dell Foundation | Q2 2026 | 510,836 | $193M | −127,709 | −20% | Aug 14, 2026 |
| Nomura Holdings | Q2 2026 | 497,781 | $188M | +434,493 | +687% | Aug 14, 2026 |
| ARK Investment Management | Q2 2026 | 407,202 | $154M | −601 | −0.1% | Aug 14, 2026 |
| Harvard Management | Q2 2026 | 338,346 | $128M | −135,570 | −29% | Aug 14, 2026 |
| UNICOM Systems | Q3 2026 | 325,300 | $114M | 0 | 0.0% | Oct 13, 2026 |
| Tensor Edge Capital | Q3 2026 | 292,500 | $103M | +92,500 | +46% | Nov 6, 2026 |
| RK Capital Management | Q2 2026 | 244,000 | $92.2M | +244,000 | New | Aug 14, 2026 |
| Nan Shan Life Insurance | Q2 2026 | 225,506 | $85.2M | +78,335 | +53% | Aug 14, 2026 |
| Patient Capital Management | Q3 2026 | 238,453 | $83.7M | +238,453 | New | Nov 12, 2026 |
| Stony Point Capital | Q2 2026 | 218,203 | $82.4M | +7,170 | +3.4% | Aug 13, 2026 |
| Soma Equity Partners | Q2 2026 | 170,762 | $64.5M | +170,762 | New | Aug 14, 2026 |
| Soros Fund Management | Q2 2026 | 165,246 | $62.4M | +10,139 | +6.5% | Aug 14, 2026 |
| Duquesne Family Office | Q2 2026 | 0 | — | −195,955 | Sold all | Aug 14, 2026 |
| Light Street Capital Management | Q2 2026 | 153,250 | $57.9M | +3,450 | +2.3% | Aug 14, 2026 |
| Appaloosa | Q2 2026 | 150,000 | $56.7M | +150,000 | New | Aug 14, 2026 |
| Tudor Investment Corp Et Al | Q2 2026 | 148,450 | $56.1M | −163,314 | −52% | Aug 14, 2026 |
| Jia Investment Alliance | Q3 2026 | 83,000 | $29.1M | 0 | 0.0% | Oct 6, 2026 |
| Whale Rock Capital Management | Q2 2026 | 59,780 | $22.6M | −677,362 | −92% | Aug 14, 2026 |
| Altimeter Capital Management | Q2 2026 | 0 | — | −67,094 | Sold all | Aug 14, 2026 |
| Third Point | Q2 2026 | 0 | — | −50,000 | Sold all | Aug 14, 2026 |
| Dodge & Cox | Q2 2026 | 19,290 | $7.3M | 0 | 0.0% | Aug 13, 2026 |
| Maverick Capital | Q2 2026 | 5,734 | $2.2M | +5,734 | New | Aug 14, 2026 |
| Harris Associates L P | Q2 2026 | 1,779 | $672K | −34 | −1.9% | Aug 14, 2026 |
| Renaissance Technologies | Q3 2026 | 734 | $259K | −849,101 | −100% | Nov 12, 2026 |
| Oriental Harbor Investment Master Fund | Q3 2026 | 364 | $128K | −65,583 | −99% | Oct 22, 2026 |
From the 13F filings of the 83 funds Hunch tracks, not of every institution: each fund's shares of AVGO at its latest quarter end against the quarter before, as filed (long positions only, options left out), the quarter before put on the latest quarter's share count across a split. A fund files 45 days after its quarter ends, so some have a newer quarter than others. Value is at the quarter end. Norges Bank filed its 13F for Q1 2026 confidentially, with no holdings made public, so its row compares Q2 2026 with Q4 2025.
Are insiders buying or selling?
Officers and directors bought $699K and sold $1.1B of AVGO on the open market in the 12 months to Nov 10, 2026. 83% of the sales were made under 10b5-1 plans, set up in advance. The largest was Henry Samueli (Director), who sold $878M in 64 sales.
100 sales
2 purchases
Share of the sales' value
Show every trade
| Date | Insider | Role | Trade | Shares | Price | Value | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 22,624 | $354.75 | $8.0M | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 22,946 | $355.55 | $8.2M | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 10,058 | $356.59 | $3.6M | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 6,959 | $357.66 | $2.5M | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 4,560 | $358.47 | $1.6M | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 2,162 | $359.48 | $777K | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 397 | $360.76 | $143K | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 512 | $361.48 | $185K | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 186,809 | $354.71 | $66.3M | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 230,031 | $355.50 | $81.8M | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 85,221 | $356.58 | $30.4M | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 50,998 | $357.52 | $18.2M | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 44,618 | $358.42 | $16.0M | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 22,579 | $359.44 | $8.1M | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 407 | $361.18 | $147K | Sep 25, 2026 |
| Sep 23, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 11,309 | $361.79 | $4.1M | Sep 25, 2026 |
| Jul 10, 2026 | Mark David Brazeal | Chief Legal & Corp Affairs Ofc | Sale | 25,000 | $401.33 | $10.0M | Jul 14, 2026 |
| Jul 8, 2026 | Mark David Brazeal | Chief Legal & Corp Affairs Ofc | Sale | 25,000 | $379.19 | $9.5M | Jul 10, 2026 |
| Jul 8, 2026 | Gayla J Delly | Director | Sale | 1,890 | $385.38 | $728K | Jul 10, 2026 |
| Jun 29, 2026 | Justine Page | Director | Sale | 1,602 | $373.86 | $599K | Jul 1, 2026 |
| Jun 25, 2026 | Mark David Brazeal | Chief Legal & Corp Affairs Ofc | Sale | 25,000 | $387.00 | $9.7M | Jun 29, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 23,253 | $377.61 | $8.8M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 33,346 | $378.51 | $12.6M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 30,911 | $379.76 | $11.7M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 48,996 | $380.57 | $18.6M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 36,661 | $381.68 | $14.0M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 26,889 | $382.63 | $10.3M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 36,188 | $383.69 | $13.9M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 43,302 | $384.58 | $16.7M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 53,722 | $385.57 | $20.7M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 6,280 | $386.39 | $2.4M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 660 | $388.01 | $256K | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 21,603 | $377.64 | $8.2M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 30,456 | $378.50 | $11.5M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 24,073 | $379.69 | $9.1M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 49,805 | $380.57 | $19.0M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 34,517 | $381.67 | $13.2M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 25,134 | $382.62 | $9.6M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 32,950 | $383.69 | $12.6M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 41,290 | $384.63 | $15.9M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 47,510 | $385.61 | $18.3M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 6,478 | $386.39 | $2.5M | Jun 26, 2026 |
| Jun 24, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 217 | $388.17 | $84K | Jun 26, 2026 |
| Jun 17, 2026 | Mark David Brazeal | Chief Legal & Corp Affairs Ofc | Sale | 36 | $400.29 | $14K | Jun 18, 2026 |
| Jun 16, 2026 | Mark David Brazeal | Chief Legal & Corp Affairs Ofc | Sale | 40 | $389.67 | $16K | Jun 18, 2026 |
| Jun 11, 2026 | Harry L. You | Director | Buy | 1,000 | $373.57 | $374K | Jun 15, 2026 |
| Apr 10, 2026 | S. Ram Velaga | President, ISG | Sale | 8,000 | $370.52 | $3.0M | Apr 14, 2026 |
| Apr 9, 2026 | Gayla J Delly | Director | Sale | 1,000 | $358.31 | $358K | Apr 13, 2026 |
| Apr 9, 2026 | S. Ram Velaga | President, ISG | Sale | 17,260 | $352.12 | $6.1M | Apr 10, 2026 |
| Apr 8, 2026 | Charlie B Kawwas | President, SSG | Sale | 10,000 | $345.23 | $3.5M | Apr 10, 2026 |
| Apr 8, 2026 | Justine Page | Director | Sale | 2,018 | $353.00 | $712K | Apr 10, 2026 |
| Apr 8, 2026 | S. Ram Velaga | President, ISG | Sale | 12,955 | $352.02 | $4.6M | Apr 10, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 34,308 | $317.30 | $10.9M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 44,227 | $318.39 | $14.1M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 60,049 | $319.36 | $19.2M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 48,635 | $320.31 | $15.6M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 36,183 | $321.22 | $11.6M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 17,083 | $322.23 | $5.5M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 7,328 | $323.17 | $2.4M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 2,413 | $323.92 | $782K | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 69,058 | $317.27 | $21.9M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 92,385 | $318.33 | $29.4M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 125,292 | $319.31 | $40.0M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 107,742 | $320.26 | $34.5M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 75,809 | $321.16 | $24.3M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 43,188 | $322.19 | $13.9M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 12,514 | $323.15 | $4.0M | Mar 27, 2026 |
| Mar 25, 2026 | Henry Samueli | Director | Sale (10b5-1 plan) | 5,753 | $323.90 | $1.9M | Mar 27, 2026 |
| Jan 6, 2026 | Mark David Brazeal | Chief Legal & Corp Affairs Ofc | Sale | 24,113 | $346.99 | $8.4M | Jan 8, 2026 |
| Jan 6, 2026 | Mark David Brazeal | Chief Legal & Corp Affairs Ofc | Sale | 5,887 | $347.66 | $2.0M | Jan 8, 2026 |
| Jan 6, 2026 | Hock E Tan | President and CEO; director | Sale | 27,199 | $346.75 | $9.4M | Jan 8, 2026 |
| Jan 6, 2026 | Hock E Tan | President and CEO; director | Sale | 33,078 | $347.45 | $11.5M | Jan 8, 2026 |
| Jan 6, 2026 | Hock E Tan | President and CEO; director | Sale | 9,723 | $348.28 | $3.4M | Jan 8, 2026 |
| Dec 31, 2025 | Kirsten M. Spears | CFO & Chief Accounting Officer | Sale | 23 | $346.64 | $7,973 | Jan 5, 2026 |
| Dec 31, 2025 | Kirsten M. Spears | CFO & Chief Accounting Officer | Sale | 29,977 | $347.82 | $10.4M | Jan 5, 2026 |
| Dec 26, 2025 | Mark David Brazeal | Chief Legal & Corp Affairs Ofc | Sale | 25,921 | $352.07 | $9.1M | Dec 30, 2025 |
| Dec 23, 2025 | Hock E Tan | President and CEO; director | Sale | 4,257 | $339.11 | $1.4M | Dec 29, 2025 |
| Dec 23, 2025 | Hock E Tan | President and CEO; director | Sale | 4,820 | $340.26 | $1.6M | Dec 29, 2025 |
| Dec 23, 2025 | Hock E Tan | President and CEO; director | Sale | 11,005 | $341.17 | $3.8M | Dec 29, 2025 |
| Dec 23, 2025 | Hock E Tan | President and CEO; director | Sale | 10,612 | $342.00 | $3.6M | Dec 29, 2025 |
| Dec 23, 2025 | Hock E Tan | President and CEO; director | Sale | 2,255 | $343.22 | $774K | Dec 29, 2025 |
| Dec 23, 2025 | Hock E Tan | President and CEO; director | Sale | 6,016 | $344.18 | $2.1M | Dec 29, 2025 |
| Dec 23, 2025 | Hock E Tan | President and CEO; director | Sale | 5,426 | $345.24 | $1.9M | Dec 29, 2025 |
| Dec 23, 2025 | Hock E Tan | President and CEO; director | Sale | 4,615 | $346.43 | $1.6M | Dec 29, 2025 |
| Dec 23, 2025 | Hock E Tan | President and CEO; director | Sale | 5,329 | $347.39 | $1.9M | Dec 29, 2025 |
| Dec 23, 2025 | Hock E Tan | President and CEO; director | Sale | 20,288 | $348.38 | $7.1M | Dec 29, 2025 |
| Dec 23, 2025 | Hock E Tan | President and CEO; director | Sale | 24,521 | $349.18 | $8.6M | Dec 29, 2025 |
| Dec 23, 2025 | Hock E Tan | President and CEO; director | Sale | 856 | $349.85 | $299K | Dec 29, 2025 |
| Dec 18, 2025 | Hock E Tan | President and CEO; director | Sale | 130,000 | $326.02 | $42.4M | Dec 22, 2025 |
| Dec 18, 2025 | Harry L. You | Director | Buy | 1,000 | $325.13 | $325K | Dec 22, 2025 |
| Dec 15, 2025 | Justine Page | Director | Sale (10b5-1 plan) | 800 | $361.89 | $290K | Dec 17, 2025 |
| Dec 8, 2025 | Henry Samueli | Director | Sale (10b5-1 plan) | 21,712 | $398.14 | $8.6M | Dec 9, 2025 |
| Dec 8, 2025 | Henry Samueli | Director | Sale (10b5-1 plan) | 67,610 | $399.07 | $27.0M | Dec 9, 2025 |
| Dec 8, 2025 | Henry Samueli | Director | Sale (10b5-1 plan) | 49,060 | $400.11 | $19.6M | Dec 9, 2025 |
| Dec 8, 2025 | Henry Samueli | Director | Sale (10b5-1 plan) | 131,375 | $401.02 | $52.7M | Dec 9, 2025 |
| Dec 8, 2025 | Henry Samueli | Director | Sale (10b5-1 plan) | 33,746 | $402.09 | $13.6M | Dec 9, 2025 |
| Dec 8, 2025 | Henry Samueli | Director | Sale (10b5-1 plan) | 9,590 | $402.94 | $3.9M | Dec 9, 2025 |
| Dec 8, 2025 | Henry Samueli | Director | Sale (10b5-1 plan) | 2,016 | $404.01 | $814K | Dec 9, 2025 |
| Dec 8, 2025 | Henry Samueli | Director | Sale (10b5-1 plan) | 3,854 | $405.01 | $1.6M | Dec 9, 2025 |
| Dec 8, 2025 | Henry Samueli | Director | Sale (10b5-1 plan) | 929 | $406.38 | $378K | Dec 9, 2025 |
| Dec 8, 2025 | Henry Samueli | Director | Sale (10b5-1 plan) | 424 | $407.01 | $173K | Dec 9, 2025 |
| Nov 14, 2025 | Justine Page | Director | Sale (10b5-1 plan) | 800 | $331.14 | $265K | Nov 18, 2025 |
From the Form 4s filed with the SEC about Broadcom Inc. (49 in the 12 months): purchases (code P) and sales (code S) on the open market by its officers and directors, at the price each filing gives (often an average of the day's trades). A sale is a 10b5-1 sale when its filing says it was made under such a plan, set up in advance. Not counted: 210 other transactions (grants, shares withheld for tax, shares sold to pay tax and gifts).